The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies (2013)

Chapter: Appendix E: Agendas of Public Meetings Held by the Committee

Previous Chapter: Appendix D: Study Designs for the Safety Evaluation of Different Childhood Immunization Schedules--Martin Kulldorff
Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.

Appendix E

Agendas of Public Meetings Held by the Committee

February 9, 2012
The Pew Charitable Trusts
901 E Street, NW
Washington, DC 20004

Welcome and Overview

Ada Sue Hinshaw, Ph.D., R.N.

Committee Chair

Presentation of the Charge from the National Vaccine Program Office

Bruce Gellin, M.D., M.P.H.

Deputy Assistant Secretary for Health

Director, National Vaccine Program Office, U.S. Department of Health and Human Services

Review of the IOM Committee to Review Adverse Effects of Vaccines

Ellen Wright Clayton, J.D., M.D.

Chair of the IOM Committee to Review Adverse Effects of Vaccines

Craig-Weaver Professor of Pediatrics, Vanderbilt University

National Vaccine Information Center Perspectives

Barbara Loe Fisher

Co-Founder and President, National Vaccine Information Center

Provider Perspectives

Gary Freed, M.D., M.P.H.

Professor, Department of Health Management and Policy, University of Michigan School of Public Health

Director, Division of General Pediatrics

The Percy and Mary Murphy Professor of Pediatrics and Child Health Delivery

Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
Page 201
Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
Page 202
Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
Page 203
Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
Page 204
Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
Page 205
Suggested Citation: "Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
Page 206
Next Chapter: Appendix F: Biographical Sketches of Committee Members
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.